Skip to content

Clinical trials

Lymphoma, B-Cell trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Country / region: Australia Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20072
20091
20132
20141
20173
20182
20197
20203
20218
20225
20234
202410
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting16
Active, not recruiting15
Terminated6
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.6
AstraZeneca4
Hoffmann-La Roche4
Janssen Research & Development, LLC3
Novartis Pharmaceuticals3
BeOne Medicines2
CRISPR Therapeutics AG2
Eli Lilly and Company2
Kite, A Gilead Company2
Regeneron Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell56
Lymphoma, Non-Hodgkin27
Lymphoma, Large B-Cell, Diffuse15
Lymphoma, Follicular14
Lymphoma12
Lymphoma, Mantle-Cell11
Leukemia, Lymphocytic, Chronic, B-Cell9
Recurrence9
Lymphoma, B-Cell, Marginal Zone6
Hematologic Diseases5

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.